Related Experiment Video
Updated: Feb 28, 2026
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
How do oral pathogenic bacteria potentially contribute to inflammatory processes in autoimmune liver disease? Results
Esperouz Fariba1, Villani Rosanna2, Ciavarella Domenico1
1Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71121 Foggia, Italy.
Background:
Emerging evidence suggests that the oral-gut-liver axis may play a role in the immunopathogenesis of autoimmune liver diseases (AILDs), particularly autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). Alterations in the oral microbiota may influence hepatic immune responses; however, this relationship remains poorly defined.
Objective:
This systematic review aimed to evaluate current evidence on the association between oral microbiota dysbiosis and AILDs, with a focus on microbial alterations, inflammatory profiles, and potential diagnostic implications.
Methods:
A systematic search of PubMed, Web of Science, and Scopus was conducted up to January 2026 in accordance with PRISMA guidelines. Eligible studies investigated oral microbiota composition in patients with AILDs compared with healthy controls. Data extraction was performed independently, and study quality was assessed using the Newcastle-Ottawa Scale (NOS).
Results:
Six studies published between 2015 and 2021 met the inclusion criteria, comprising 252 patients with AILDs and 345 healthy controls. All included studies reported significant oral microbiota dysbiosis in AILD patients. The most consistent findings were an increased abundance of Veillonella in AILDs and Eubacterium in the PBC subgroup, along with a reduced presence of Streptococcus and Fusobacterium. These microbial alterations were associated with elevated salivary inflammatory markers, and showed correlations with disease activity. Some studies also suggested interactions between oral and gut microbiota, potentially mediated by increased intestinal permeability and bacterial translocation.
Conclusions:
Current evidence supports an association between oral microbiota dysbiosis and inflammatory mechanisms. Although causality cannot be established, the oral-gut-liver axis may represent a promising source of biomarkers and therapeutic targets.
Related Concept Videos
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...